In this episode of Inside the Lab, Patricia Delgado and Liz Etkin-Kramer explore the evolving landscape of cervical cancer screening amid recent guideline updates emphasizing primary HPV testing, self-collection, and revised screening exit criteria. The conversation examines the challenges posed by HPV-negative cervical cancers and highlights the importance of close collaboration between pathology and OB-GYN teams when screening results, clinical findings, and patient presentation do not align neatly. Through a detailed case discussion, the guests describe how ongoing communication and iterative review between specialties ultimately leads to improved diagnostic accuracy in difficult cases, underscoring the value of interdisciplinary partnership in complex gynecologic cases.Key TakeawaysRecent cervical cancer screening updates are not yet fully harmonized across major professional organizations, creating a transitional landscape that clinicians and laboratories must navigate carefully.HPV-negative cervical lesions and cancers can present significant diagnostic challenges, particularly when standard screening results do not match clinical suspicion.Strong, iterative collaboration between OB-GYNs and pathologists can be critical for resolving complex cases and achieving accurate diagnoses, as illustrated by the discussion of lobular endocervical glandular hyperplasia.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related